Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

[Pioglitazone-induced acute severe hepatitis].

Arotçarena R, Bigué JP, Etcharry F, Pariente A.

Gastroenterol Clin Biol. 2004 Jun-Jul;28(6-7 Pt 1):610-1. French. No abstract available.

2.

Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.

Osei SY, Koro CE, Cobitz AR, Kolatkar NS, Stender M.

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1244-6. doi: 10.1002/pds.1840. No abstract available.

PMID:
19655316
3.

Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al.

Beiderbeck AB, Sakaguchi M.

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1247-9. doi: 10.1002/pds.1872. No abstract available.

PMID:
19842093
4.

Second-generation thiazolidinediones and hepatotoxicity.

Marcy TR, Britton ML, Blevins SM.

Ann Pharmacother. 2004 Sep;38(9):1419-23.

PMID:
15266041
5.

[The benefit of pioglitazone in patients with diabetes mellitus type 2 and cardiovascular complications].

Olsovský J.

Vnitr Lek. 2005 Dec;51(12):1412. Czech. No abstract available.

PMID:
16430111
6.

[Pioglitazone].

Aso Y.

Nihon Rinsho. 2012 May;70 Suppl 3:620-6. Japanese. No abstract available.

PMID:
22768588
7.

Options sought after drug study. Patients who take rosiglitazone might consider pioglitazone instead.

[No authors listed]

Heart Advis. 2007 Jul;10(7):9. No abstract available.

PMID:
17703512
8.

Severe but reversible hepatitis induced by troglitazone.

Schiano T, Dolehide K, Hart J, Baker AL.

Dig Dis Sci. 2000 May;45(5):1039-42. No abstract available.

PMID:
10795774
9.

Pioglitazone-induced progressive pancytopenia.

Favre G, Valnet-Rabier MB, Brousse A, Lepiller Q, Kantelip JP.

Ann Pharmacother. 2011 Jan;45(1):131-3. doi: 10.1345/aph.1P497. No abstract available.

PMID:
21205948
10.

Hepatic injury due to troglitazone.

Malik AH, Prasad P, Saboorian MH, Thiele DL, Malet PF.

Dig Dis Sci. 2000 Jan;45(1):210-4. Review. No abstract available.

PMID:
10695637
11.

Pioglitazone and bladder cancer: the pros and cons.

Panikar V.

J Assoc Physicians India. 2012 Jan;60:72-3. No abstract available.

PMID:
22715550
12.

[Treatment of patients with type 2 diabetes mellitus with pioglitazone. A survey of a Cochrane review].

Madsbad S.

Ugeskr Laeger. 2007 Nov 19;169(47):4054-7. Review. Danish. No abstract available.

PMID:
18078659
13.

Pioglitazone--quo vadis?

Shah SN, Billimoria A.

J Assoc Physicians India. 2012 Jan;60:12. No abstract available.

PMID:
22715540
14.

Pioglitazone + glimepiride: a combination product to avoid.

[No authors listed]

Prescrire Int. 2007 Aug;16(90):145. No abstract available.

PMID:
17724836
15.

Pioglitazone/glimepiride (Duetact) for diabetes.

[No authors listed]

Med Lett Drugs Ther. 2007 Jan 29;49(1253):9-11. No abstract available.

PMID:
17261966
16.

Rosiglitazone and pioglitazone in the treatment of diabetes mellitus.

Odom J, Williamson B, Carter L.

Am J Health Syst Pharm. 2008 Oct 1;65(19):1846-50. doi: 10.2146/ajhp070659. No abstract available.

PMID:
18796427
17.

Pioglitazone/metformin (Actoplus met).

[No authors listed]

Med Lett Drugs Ther. 2006 Jan 30;48(1227):9-11. No abstract available.

PMID:
16444136
18.

Pioglitazone: Hype and hope.

Jadhav SS, Shivane VK, Lila AR, Bandgar TR, Shah NS.

J Postgrad Med. 2014 Jul-Sep;60(3):293-6. doi: 10.4103/0022-3859.138765. No abstract available.

19.

Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.

Fujimoto K, Hamamoto Y, Honjo S, Kawasaki Y, Mori K, Tatsuoka H, Matsuoka A, Wada Y, Ikeda H, Fujikawa J, Koshiyama H.

Diabetes Res Clin Pract. 2013 Feb;99(2):e21-3. doi: 10.1016/j.diabres.2012.11.013.

PMID:
23228390
20.

The value equation for rosiglitazone and pioglitazone in older persons.

Zarowitz BJ.

Geriatr Nurs. 2008 Jan-Feb;29(1):9-11. doi: 10.1016/j.gerinurse.2007.11.004. No abstract available.

PMID:
18267172
Items per page

Supplemental Content

Support Center